Hughes Financial Services’s Maze Therapeutics MAZE Stock Holding History

Hughes Financial Services’s Portfolio MAZE Stock Details MAZE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1	Closed	-$30	–	1949
2026 Q1	$30	Buy	+1	New	+$44	﹤0.01%	1550

Other funds holding MAZE

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Falcon Wealth Planning Ontario, California $1.58B AUM 20.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Torren Management San Diego, California $197M AUM

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Hughes Financial Services's MAZE Position: Q2 2026 in Review

Hughes Financial Services sold out of Maze Therapeutics (MAZE) in Q2 2026, closing a stake of 1 share — an estimated $30 sold.

Hughes Financial Services first reported a position in MAZE in Q1 2026 and held it in 1 quarter. The position peaked at $30 in Q1 2026. 7 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

Hughes Financial Services reported no remaining Maze Therapeutics position as of Q2 2026 after selling out during the quarter.
Hughes Financial Services sold 1 Maze Therapeutics share in Q2 2026, an estimated $30.
Hughes Financial Services first reported a position in Maze Therapeutics in Q1 2026 and held it in 1 quarter.
Hughes Financial Services's Maze Therapeutics position peaked at $30 in Q1 2026.
7 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.